Literature DB >> 10092774

Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.

P Kaliński1, J H Schuitemaker, C M Hilkens, E A Wierenga, M L Kapsenberg.   

Abstract

Activation of immature CD83- dendritic cells (DC) in peripheral tissues induces their maturation and migration to lymph nodes. Activated DC become potent stimulators of Th cells and efficient inducers of Th1- and Th2-type cytokine production. This study analyzes the ability of human monocyte-derived CD1a+ DC at different stages of IL-1 beta and TNF-alpha-induced maturation to produce the major Th1-driving factor IL-12. DC at the early stages of maturation (2 and 4 h) produced elevated amounts of IL-12 p70 during interaction with CD40 ligand-bearing Th cells or, after stimulation with the T cell-replacing factors, soluble CD40 ligand and IFN-gamma. The ability to produce IL-12 was strongly down-regulated at later time points, 12 h after the induction of DC maturation, and in fully mature CD83+ cells, at 48 h. In contrast, the ability of mature DC to produce IL-6 was preserved or even enhanced, indicating their intact responsiveness to CD40 triggering. A reduced IL-12-producing capacity of mature DC resulted mainly from their impaired responsiveness to IFN-gamma, a cofactor in CD40-induced IL-12 p70 production. This correlated with reduced expression of IFN-gamma R (CD119) by mature DC. In addition, while immature DC produced IL-12 and IL-6 after stimulation with LPS or Staphylococcus aureus Cowan I strain, mature DC became unresponsive to these bacterial stimuli. Together with the previously described ability of IL-10 and PGE2 to stably down-regulate the ability to produce IL-12 in maturing, but not in fully mature, DC, the current data indicate a general resistance of mature DC to IL-12-modulating factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092774

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Filarial antigens impair the function of human dendritic cells during differentiation.

Authors:  R T Semnani; H Sabzevari; R Iyer; T B Nutman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells.

Authors:  Chifu B Huang; Yelena V Alimova; Samantha Strange; Jeffrey L Ebersole
Journal:  Immunology       Date:  2010-11-12       Impact factor: 7.397

4.  Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.

Authors:  Davorka Messmer; Gloria Telusma; Tarun Wasil; Bradley T Messmer; Steven Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

5.  DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.

Authors:  Anne Flörcken; Joachim Kopp; Uwe Kölsch; Christian Meisel; Bernd Dörken; Antonio Pezzutto; Jörg Westermann
Journal:  Hum Vaccin Immunother       Date:  2016-02-10       Impact factor: 3.452

Review 6.  Dendritic cell-mediated T cell polarization.

Authors:  Esther C de Jong; Hermelijn H Smits; Martien L Kapsenberg
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

7.  Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Rachel Elizabeth Martin; Tomoki Ito; Farrah Kheradmand; David Brian Corry; Yong-Jun Liu; Matthew Moyle
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 8.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Authors:  Pawel Kalinski
Journal:  Curr Opin Investig Drugs       Date:  2009-06

10.  Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Authors:  Brooke M Helfer; Anthony Balducci; Aaron D Nelson; Jelena M Janjic; Roberto R Gil; Pawel Kalinski; I Jolanda M de Vries; Eric T Ahrens; Robbie B Mailliard
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.